email exchange with michael, page-111

Thanks kindly Massey,

Yes, I remain interested in all connected technology innovations within the healthcare sector - significant momentum in this area now - just a matter of picking the right company at the right time - easier said than done.

I'm also heavily invested in someone who was connected to this company a long time ago, even before the aquisition of KarmelSonix and the name change from Salus Technologies - GlaxoSmithKline in the UK are also heavily invested in the same person, although no one yet knows exactly what development programs all the confidentiality agreements relate to, so I'm natually interested in everything this person has ever been involved with.
___

Ah Metro, you make it so tempting but I think it's closer to 20 years "in the making" and as posted yesterday, a study completed in July last year concluded that lower sensitivity and high variability among patients is a preventing factor for wheeze rate to be used as a precise predictor of FEV1.

You do know what product this study related to don't you? Although it still states, currently recruiting participants, it also appears as though it was abandoned around the same time as the changing of the guards and company name last year - Wheezometer™ Exploratory (WM) Field Study

As for, "if anyone else had the ability of ISN products, they would've already come out with it"...

They did and they already have...

Have you heard of Masimo Inc. Metro?

April 5, 2007
New Research Shows Masimo Acoustic Respiratory Monitoring Technology Provides 'Significantly More Reliable Monitoring of Respiration Rate - Source

Rainbow Acoustic Monitoring™ noninvasively and continuously measures respiration rate using an innovative adhesive sensor with an integrated acoustic transducer that is easily and comfortably applied to the patient's neck.

Using acoustic signal processing that leverages Masimo's patented revolutionary Signal Extraction Technology (SET®), the respiratory signal is separated and processed to display continuous respiration rate. - Rainbow Acoustic Monitoring™

Masimo's product revenue rose 14% to $406.5 million in 2011.
___

Have you heard of ParkerVision Inc. Metro?

ParkerVision, Inc. designs, develops and markets its proprietary RF technologies, which enable advanced wireless communications for current and next generation mobile communications networks. The company's award winning IP portfolio includes 188 domestic and international patents.

15 February 2012
ParkerVision's lawsuit seeks monetary damages from Qualcomm as well as a permanent injunction barring the manufacture and sale of Qualcomm's infringing devices. Additionally, the complaint accuses Qualcomm of willfully infringing and seeks an award of exemplary damages, attorneys' fees and related court costs.
___

Personally, I believe ParkerVision will have a difficult time winning the case, however the infringing patents relate to radio-frequency receivers and the down-conversion of electromagnetic signals, which represent a body of intellectual property that ParkerVision pioneered so the Markman hearing, which is set for August 10, 2012 will set a precedent, and if undefeated may have a detrimental impact on the Qualcomm's relationship with Isonea.